Related Experiment Video
Updated: Jul 4, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
A Gaussian-Based Planning Approach for Robust Dose-Escalated Stereotactic Body Proton Therapy
Xiandong Zhao1, Thomas R Mazur1, Hailei Zhang1
1Department of Radiation Oncology, WashU Medicine, St. Louis, Missouri.
Summary
A new Gaussian-based planning technique for stereotactic body proton therapy (SBPT) mimics photon SBRT dose distributions. This approach enhances biologically effective dose and may allow for safe dose escalation in liver cancer treatment.
Area of Science:
- Radiation Oncology
- Medical Physics
- Cancer Treatment
Background:
- Proton therapy plans often lack the dose heterogeneity seen in photon SBRT.
- This homogeneity may limit the effectiveness of proton therapy for ablative treatments.
- Stereotactic body proton therapy (SBPT) requires planning strategies to optimize dose distribution.
Purpose of the Study:
- To develop and evaluate a novel treatment planning approach for SBPT.
- The goal is to replicate photon SBRT dose characteristics, including high central doses and rapid falloff.
- This aims to improve dose escalation potential and clinical data harmonization.
Main Methods:
- A semi-automated Gaussian-based planning technique was developed.
- The technique divides the gross tumor volume (GTV) into shells to shape dose falloff.
- The method was tested on 10 liver SBPT patients, comparing Gaussian plans to standard homogeneous plans.
Main Results:
- Gaussian plans achieved hotspots within 2.2% of target values.
- Biologically effective dose significantly increased by 20 Gy (α/β=10) compared to homogeneous plans.
- While PTV dose spill was slightly higher, Gaussian plans showed lower gastrointestinal organ-at-risk doses and a trend for lower mean liver dose.
Conclusions:
- A novel, mathematically driven technique for liver SBPT planning was successfully developed and tested.
- The Gaussian approach effectively mimics photon SBRT dose distributions.
- This technique may enable safe dose escalation and better integration with existing SBRT clinical data.

